• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人氨甲酰磷酸合成酶I基因(CPS1)的结构组织及两种新遗传损伤的鉴定。

Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions.

作者信息

Funghini S, Donati M A, Pasquini E, Zammarchi E, Morrone A

机构信息

Metabolic and Neuromuscular Unit, Department of Pediatrics, University of Florence, Florence, Italy.

出版信息

Hum Mutat. 2003 Oct;22(4):340-1. doi: 10.1002/humu.9184.

DOI:10.1002/humu.9184
PMID:12955727
Abstract

Carbamyl Phosphate Synthetase I deficiency (CPSID) is a rare autosomal recessive urea cycle disorder usually characterized by potentially lethal neonatal hyperammonemia. The large (5215 bp) CPS1-cDNA, expressed only in liver and epithelial cells of intestinal mucosa, has been cloned. Until now the CPS1 genomic organization was unknown. Taking advantage of the phylogenetic lineage between the CPS1 gene of Homo sapiens and Rattus norvegicus, we determined the intron-exon organization of the human CPS1 gene. Starting from the ATG codon, the CPS I gene is organized in 38 exons spanning from 50bp to 200 bp. We also report the molecular studies on an Italian patient affected by neonatal CPSD. Two novel genetic lesions (c.1370T>G and c.2429A>G) that lead to the novel amino acid substitutions V457G and Q810R, and the known N1406T polymorphism, were detected in the patient's CPS1 RNA and in genomic DNA isolated from peripheral blood lymphocytes. The characterization of the CPS1 genomic organization will allow the identification of the genetic lesions of CPSD patients, the detection of carriers, better genetic counseling and a more certain, less invasive method of prenatal diagnosis.

摘要

氨甲酰磷酸合成酶I缺乏症(CPSID)是一种罕见的常染色体隐性尿素循环障碍疾病,通常表现为具有潜在致死性的新生儿高氨血症。仅在肝脏和肠黏膜上皮细胞中表达的大的(5215 bp)CPS1 - cDNA已被克隆。到目前为止,CPS1的基因组结构尚不清楚。利用智人与褐家鼠CPS1基因之间的系统发育谱系,我们确定了人类CPS1基因的内含子 - 外显子结构。从起始密码子ATG开始,CPS I基因由38个外显子组成,长度从50bp到200bp不等。我们还报告了对一名患有新生儿CPSD的意大利患者的分子研究。在患者的CPS1 RNA和从外周血淋巴细胞分离的基因组DNA中检测到两个导致新的氨基酸取代V457G和Q810R的新的基因病变(c.1370T>G和c.2429A>G),以及已知的N1406T多态性。CPS1基因组结构的表征将有助于识别CPSD患者的基因病变、检测携带者、提供更好的遗传咨询以及一种更确定、侵入性更小的产前诊断方法。

相似文献

1
Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions.人氨甲酰磷酸合成酶I基因(CPS1)的结构组织及两种新遗传损伤的鉴定。
Hum Mutat. 2003 Oct;22(4):340-1. doi: 10.1002/humu.9184.
2
Novel human pathological mutations. Gene symbol: CPS1. Disease: carbamoyl phosphate synthetase I deficiency.新型人类病理突变。基因符号:CPS1。疾病:氨甲酰磷酸合成酶I缺乏症。
Hum Genet. 2009 Apr;125(3):336.
3
Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohort.意大利的氨甲酰磷酸合成酶 1 缺乏症:在一个异质队列中的临床和遗传发现。
Gene. 2012 Feb 10;493(2):228-34. doi: 10.1016/j.gene.2011.11.052. Epub 2011 Dec 7.
4
Gene structure of human carbamylphosphate synthetase 1 and novel mutations in patients with neonatal onset.人氨甲酰磷酸合成酶1的基因结构及新生儿期发病患者的新突变
Hum Mutat. 2003 Apr;21(4):444. doi: 10.1002/humu.9118.
5
Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis.利用表达研究和基于结构的分析来理解氨甲酰磷酸合成酶 I (CPS1) 缺乏症。
Hum Mutat. 2010 Jul;31(7):801-8. doi: 10.1002/humu.21272.
6
Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression?一家系中氨甲酰磷酸合成酶 1 缺乏的高度可变临床表型:是否为基因表达中等位基因变异的影响?
Clin Genet. 2009 Sep;76(3):263-9. doi: 10.1111/j.1399-0004.2009.01216.x.
7
Carbamyl phosphate synthetase I deficiency. One base substitution in an exon of the CPS I gene causes a 9-basepair deletion due to aberrant splicing.氨甲酰磷酸合成酶I缺乏症。CPS I基因一个外显子中的一个碱基替换由于异常剪接导致9个碱基对缺失。
J Clin Invest. 1993 May;91(5):1884-7. doi: 10.1172/JCI116405.
8
Recurrence of carbamoyl phosphate synthetase 1 (CPS1) deficiency in Turkish patients: characterization of a founder mutation by use of recombinant CPS1 from insect cells expression.土耳其患者中氨甲酰磷酸合成酶1(CPS1)缺乏症的复发:通过使用昆虫细胞表达的重组CPS1对一个奠基者突变进行特征分析。
Mol Genet Metab. 2014 Dec;113(4):267-73. doi: 10.1016/j.ymgme.2014.09.014. Epub 2014 Oct 7.
9
Prenatal diagnosis of carbamoyl phosphate synthetase I deficiency by identification of a missense mutation in CPS1.通过鉴定CPS1中的错义突变进行氨甲酰磷酸合成酶I缺乏症的产前诊断。
Hum Mutat. 1998;12(3):206-11. doi: 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.0.CO;2-E.
10
Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.条件性敲除小鼠肝脏中的氨甲酰磷酸合成酶 1 可导致高氨血症而无乳清酸尿症,肝靶向基因治疗可纠正该缺陷。
Mol Genet Metab. 2018 Aug;124(4):243-253. doi: 10.1016/j.ymgme.2018.04.001. Epub 2018 Apr 12.

引用本文的文献

1
Identification of novel variants in carbamoyl phosphate synthetase 1 gene and comparative pathogenicity assessments of CPS1 missense variants following ACMG/AMP-ClinGen recommendation for computational tools.根据美国医学遗传学与基因组学学会(ACMG)/临床基因组资源(ClinGen)针对计算工具的建议,鉴定氨甲酰磷酸合成酶1基因中的新型变异,并对CPS1错义变异进行致病性比较评估。
Mol Genet Metab Rep. 2025 Mar 22;43:101208. doi: 10.1016/j.ymgmr.2025.101208. eCollection 2025 Jun.
2
Identification of rare variants causing urea cycle disorders: A clinical, genetic, and biophysical study.鉴定导致尿素循环障碍的罕见变异:临床、遗传和生物物理研究。
J Cell Mol Med. 2021 Apr;25(8):4099-4109. doi: 10.1111/jcmm.16379. Epub 2021 Feb 21.
3
CPS1: Looking at an ancient enzyme in a modern light.
CPS1:用现代的眼光看待古老的酶。
Mol Genet Metab. 2020 Nov;131(3):289-298. doi: 10.1016/j.ymgme.2020.10.003. Epub 2020 Oct 10.
4
Biallelic mutations in carbamoyl phosphate synthetase 1 induced hyperammonemia in a neonate: A case report.氨甲酰磷酸合成酶1双等位基因突变导致新生儿高氨血症:一例报告
Exp Ther Med. 2020 Jul;20(1):623-629. doi: 10.3892/etm.2020.8717. Epub 2020 May 6.
5
Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations.人氨甲酰磷酸合成酶 I 中的分子缺陷:突变谱、诊断和蛋白质结构考虑。
Hum Mutat. 2011 Jun;32(6):579-89. doi: 10.1002/humu.21406. Epub 2011 May 5.
6
Contrasting features of urea cycle disorders in human patients and knockout mouse models.人类患者和基因敲除小鼠模型中尿素循环障碍的对比特征。
Mol Genet Metab. 2008 Jan;93(1):7-14. doi: 10.1016/j.ymgme.2007.08.123. Epub 2007 Oct 22.
7
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency.日本氨甲酰磷酸合成酶1(CPS1)缺乏症患者的分子与临床分析。
J Hum Genet. 2007;52(4):349-354. doi: 10.1007/s10038-007-0122-9. Epub 2007 Feb 20.
8
Successful prenatal molecular diagnosis of carbamyl-phosphate synthetase I deficiency in two at-risk pregnancies.在两例高危妊娠中成功进行氨甲酰磷酸合成酶I缺乏症的产前分子诊断。
J Inherit Metab Dis. 2005;28(5):801-2. doi: 10.1007/s10545-005-0053-6.